MVT in Silico Logo

Physics Driven Drug Development
Derisking R&D Workflows:
From Discovery Stage to Clinical Trials Using Modelling & Simulation

Introduction
MVT in Silico is a life sciences R&D company that specializes in leveraging physiologically based computer modelling analyses to advance your drug development (medical treatment) programs from molecular development to virtual clinical trials for your first in human studies. We will minimize recall of your investigational new drug (IND) submissions, and following submissions (BLA, NDA). We develop human focused computational solutions in life sciences, as a pre-cursor & complement to physical experiments. Our first market ready solution is a pharmacometrics software for use in treatment developmentresearch. The software is called the MVT Physiology Engine.
Our services reduce your uncertainty in research and regulatory questions, increasing confidence in the development of your asset. Our core technologies are indication agnostic capable of serving your program. We have validated expertise in assisted reproduction therapies (women), cerebrovascular treatments, and cardiac arrhythmia treatments.

The Vision
We envision a better future for drug development that harnesses existing scientific knowledge as encoded into our modelling and simulation platforms, and where medicines are safer while we eliminate redundant physical experimentation and clinical trial burden. We are doing this without compromise on our the highest standards of scientific rigor and innovation.

Our Mission
To provide objective, high quality, and timely development support that leverages our expertise and the evolving regulatory landscape to developers of drugs, drug-device combinations, and devices.

Lets Get Started!!
Our work with you starts with in depth discussions to clarify the problem you are solving into a well defined question. Ready? Get in touch for a no obligation consultation.